Cargando…
Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in E...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333700/ https://www.ncbi.nlm.nih.gov/pubmed/34368250 http://dx.doi.org/10.3389/fcvm.2021.690116 |
_version_ | 1783733023091458048 |
---|---|
author | Wu, Min Yu, Zongliang Li, Xiaoya Zhang, Xiaonan Wang, Songzi Yang, Shengjie Hu, Lanqing Liu, Longtao |
author_facet | Wu, Min Yu, Zongliang Li, Xiaoya Zhang, Xiaonan Wang, Songzi Yang, Shengjie Hu, Lanqing Liu, Longtao |
author_sort | Wu, Min |
collection | PubMed |
description | With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in Eastern countries. Paeonol is an active ingredient extracted from Paeonia suffruticosa. Previous studies have extensively explored the clinical benefits of paeonol. However, comprehensive reviews on the cardiovascular protective effects of paeonol have not been conducted. The current review summarizes studies reporting on the protective effects of paeonol on the cardiovascular system. This study includes studies published in the last 10 years. The biological characteristics of Paeonia suffruticosa, pharmacological mechanisms of paeonol, and its toxicological and pharmacokinetic characteristics were explored. The findings of this study show that paeonol confers protection against atherosclerotic cardiovascular disease through various mechanisms, including inflammation, platelet aggregation, lipid metabolism, mitochondria damage, endoplasmic reticulum stress, autophagy, and non-coding RNA. Further studies should be conducted to elucidate the cardiovascular benefits of paeonol. |
format | Online Article Text |
id | pubmed-8333700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83337002021-08-05 Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview Wu, Min Yu, Zongliang Li, Xiaoya Zhang, Xiaonan Wang, Songzi Yang, Shengjie Hu, Lanqing Liu, Longtao Front Cardiovasc Med Cardiovascular Medicine With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in Eastern countries. Paeonol is an active ingredient extracted from Paeonia suffruticosa. Previous studies have extensively explored the clinical benefits of paeonol. However, comprehensive reviews on the cardiovascular protective effects of paeonol have not been conducted. The current review summarizes studies reporting on the protective effects of paeonol on the cardiovascular system. This study includes studies published in the last 10 years. The biological characteristics of Paeonia suffruticosa, pharmacological mechanisms of paeonol, and its toxicological and pharmacokinetic characteristics were explored. The findings of this study show that paeonol confers protection against atherosclerotic cardiovascular disease through various mechanisms, including inflammation, platelet aggregation, lipid metabolism, mitochondria damage, endoplasmic reticulum stress, autophagy, and non-coding RNA. Further studies should be conducted to elucidate the cardiovascular benefits of paeonol. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8333700/ /pubmed/34368250 http://dx.doi.org/10.3389/fcvm.2021.690116 Text en Copyright © 2021 Wu, Yu, Li, Zhang, Wang, Yang, Hu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wu, Min Yu, Zongliang Li, Xiaoya Zhang, Xiaonan Wang, Songzi Yang, Shengjie Hu, Lanqing Liu, Longtao Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title | Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title_full | Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title_fullStr | Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title_full_unstemmed | Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title_short | Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview |
title_sort | paeonol for the treatment of atherosclerotic cardiovascular disease: a pharmacological and mechanistic overview |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333700/ https://www.ncbi.nlm.nih.gov/pubmed/34368250 http://dx.doi.org/10.3389/fcvm.2021.690116 |
work_keys_str_mv | AT wumin paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT yuzongliang paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT lixiaoya paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT zhangxiaonan paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT wangsongzi paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT yangshengjie paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT hulanqing paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview AT liulongtao paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview |